Pharmacokinetics of olmesartan medoxomil in hemodialysis patients: little effect of dialysis upon its pharmacokinetics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetics of olmesartan medoxomil in hemodialysis patients: little effect of dialysis upon its pharmacokinetics

Published:2009-02 Issue:1 Volume:13 Page:61-65
ISSN:1342-1751
Container-title:Clinical and Experimental Nephrology
language:en
Short-container-title:Clin Exp Nephrol

Author:

Tanaka Hirotaka,Nagasawa Yasuyuki,Matsui Isao,Hamano Takayuki,Iwatani Hirotsugu,Kawada Noritaka,Horio Masaru,Ito Takahito,Isaka Yoshitaka,Imai Enyu

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Nephrology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10157-008-0067-0.pdf

Reference13 articles.

1. Schmieder RE. Mechanisms for the clinical benefits of angiotensin II receptor blockers. Am J Hypertens. 2005;18(5 Pt 1):720–30.

2. Sica DA. Renal handling of angiotensin receptor blockers: clinical relevance. Curr Hypertens Rep. 2003;5(4):337–9.

3. Pfister M, et al. Pharmacokinetics and haemodynamics of candesartan cilexetil in hypertensive patients on regular haemodialysis. Br J Clin Pharmacol. 1999;47(6):645–51.

4. Takahashi A, et al. Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis—a randomized study. Nephrol Dial Transplant. 2006;21(9):2507–12.

5. Pun PH, et al. Predictors of survival after cardiac arrest in outpatient hemodialysis clinics. Clin J Am Soc Nephrol. 2007;2(3):491–500.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Décès toxique à l’amlodipine et l’olmésartan : à propos d’un cas avec pharmacobézoard;Toxicologie Analytique et Clinique;2016-12

2. Clearance of cardiovascular medications during hemodialysis;Current Opinion in Nephrology and Hypertension;2016-05

3. Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis;The Journal of Clinical Pharmacology;2015-12-22

4. Terahertz Spectroscopic and Density Functional Theoretical Analysis of Cocrystal Between Olmesartan and Benzoic Acid;CHEM J CHINESE U;2015

5. Dialysis-Associated Hypertension Treated with Telmisartan – DiaTel: A Pilot, Placebo-Controlled, Cross-Over, Randomized Trial;PLoS ONE;2013-11-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3